Gabelli & CO Investment Advisers, Inc. Cure Vac N.V. Transaction History
Gabelli & CO Investment Advisers, Inc.
- $584 Million
- Q2 2025
A detailed history of Gabelli & CO Investment Advisers, Inc. transactions in Cure Vac N.V. stock. As of the latest transaction made, Gabelli & CO Investment Advisers, Inc. holds 26,050 shares of CVAC stock, worth $139,628. This represents 0.02% of its overall portfolio holdings.
Number of Shares
26,050Holding current value
$139,628% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CVAC
# of Institutions
102Shares Held
14.2MCall Options Held
270KPut Options Held
114K-
Black Rock Inc. New York, NY2.25MShares$12.1 Million0.0% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ1.97MShares$10.6 Million0.58% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$8.41 Million10.6% of portfolio
-
Qube Research & Technologies LTD London, X01.18MShares$6.34 Million0.01% of portfolio
-
Water Island Capital LLC New York, NY957KShares$5.13 Million1.03% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $1B
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...